Charley Grant

Industrials and health care for @wsjheard. Heralded by critics as "most lamentable.”

Categories
N/A
Content Types
N/A
More Information
Location|Languages
Publications

Published Content

320
Why Mylan, Not Tesla, Is the Buyout to Bet On
wsj.comArticle
Why Mylan, Not Tesla, Is the Buyout to Bet On
August, 8 2018
テスラ非公開化の夢、残る数々の疑問
jp.wsj.comArticle
テスラ非公開化の夢、残る数々の疑問
August, 7 2018
Tesla’s Go-Private Dream Doesn’t Add Up
wsj.comArticle
Tesla’s Go-Private Dream Doesn’t Add Up
August, 7 2018
テスラの見通し、投資家好感も要注意
jp.wsj.comArticle
テスラの見通し、投資家好感も要注意
August, 2 2018
Tesla Profits: Be Careful What You Wish For
wsj.comArticle
Tesla Profits: Be Careful What You Wish For
August, 1 2018
MiMedx Gets Delisting Notice From Nasdaq
wsj.comArticle
MiMedx Gets Delisting Notice From Nasdaq
July, 26 2018
Caution Still Needed on Biogen Alzheimer’s Bounty
wsj.comArticle
Caution Still Needed on Biogen Alzheimer’s Bounty
July, 26 2018
テスラは「寄付」が命綱に、資金繰り探るマスク氏
jp.wsj.comArticle
テスラは「寄付」が命綱に、資金繰り探るマスク氏
July, 23 2018
Tesla Wants Its Money Back
wsj.comArticle
Tesla Wants Its Money Back
July, 23 2018
Biotech IPO Boom Comes With Side Effects
wsj.comArticle
Biotech IPO Boom Comes With Side Effects
July, 18 2018
株価を押し上げる「取り残される不安」
jp.wsj.comArticle
株価を押し上げる「取り残される不安」
July, 13 2018
Fear of Missing Out Drives Stock Performance
wsj.comArticle
Fear of Missing Out Drives Stock Performance
July, 13 2018
Drug Supply Chain Feels the Trump Effect
wsj.comArticle
Drug Supply Chain Feels the Trump Effect
July, 11 2018
Don’t Chase Biogen Into the Unknown on Alzheimer’s
wsj.comArticle
Don’t Chase Biogen Into the Unknown on Alzheimer’s
July, 6 2018
Why July Is a Risky Month for Drug Price Backlash
wsj.comArticle
Why July Is a Risky Month for Drug Price Backlash
July, 3 2018
テスラの生産目標達成、投資家は油断ならず
jp.wsj.comArticle
テスラの生産目標達成、投資家は油断ならず
July, 3 2018
Tesla’s Big Number Doesn’t Solve Its Problems
wsj.comArticle
Tesla’s Big Number Doesn’t Solve Its Problems
July, 2 2018
アマゾンの参入でドラッグストア業界に「悪寒」
jp.wsj.comArticle
アマゾンの参入でドラッグストア業界に「悪寒」
June, 28 2018
How Amazon Made Pharmacies Ill
wsj.comArticle
How Amazon Made Pharmacies Ill
June, 28 2018
テスラ「モデル3」の生産、悪い癖は直るのか
jp.wsj.comArticle
テスラ「モデル3」の生産、悪い癖は直るのか
June, 28 2018
Tesla’s Busy and Worrisome Week
wsj.comArticle
Tesla’s Busy and Worrisome Week
June, 27 2018
Sizing Up Tesla’s $10 Billion Debt Stack
wsj.comArticle
Sizing Up Tesla’s $10 Billion Debt Stack
June, 17 2018
Stryker Offer May Trigger Billions in Deal Making
wsj.comArticle
Stryker Offer May Trigger Billions in Deal Making
June, 11 2018
Allergan Needs a New Wrinkle
wsj.comArticle
Allergan Needs a New Wrinkle
June, 6 2018
バイオ企業ネクターの時価総額、1日で60億ドル吹き飛ぶ
jp.wsj.comArticle
バイオ企業ネクターの時価総額、1日で60億ドル吹き飛ぶ
June, 5 2018
In Biotech, $6 Billion Can Vanish Quickly
wsj.comArticle
In Biotech, $6 Billion Can Vanish Quickly
June, 4 2018
Tesla’s Numbers Are Even More Dramatic Than Its CEO
wsj.comArticle
Tesla’s Numbers Are Even More Dramatic Than Its CEO
May, 5 2018
テスラ、隠し切れない資金難
jp.wsj.comArticle
テスラ、隠し切れない資金難
May, 3 2018
Tesla Can’t Make Its Cash Problems Disappear
wsj.comArticle
Tesla Can’t Make Its Cash Problems Disappear
May, 2 2018
Big Pharma’s Strategy Is Music to Biotech Investors’ Ears
wsj.comArticle
Big Pharma’s Strategy Is Music to Biotech Investors’ Ears
May, 1 2018
米株市場、決算好調でも反応薄のわけ
jp.wsj.comArticle
米株市場、決算好調でも反応薄のわけ
April, 30 2018
Stocks Have an Earnings Problem
wsj.comArticle
Stocks Have an Earnings Problem
April, 30 2018
Biogen Investors Are Losing Patience
wsj.comArticle
Biogen Investors Are Losing Patience
April, 24 2018
Honeywell Sounds the Charge for Industrial Stocks
wsj.comArticle
Honeywell Sounds the Charge for Industrial Stocks
April, 20 2018
武田とシャイアー、「三度目の正直」にならない理由
jp.wsj.comArticle
武田とシャイアー、「三度目の正直」にならない理由
April, 19 2018
Third Time Unlucky for Takeda and Shire
wsj.comArticle
Third Time Unlucky for Takeda and Shire
April, 19 2018
テスラ、「モデル3」生産停止で計画振り出しに
jp.wsj.comArticle
テスラ、「モデル3」生産停止で計画振り出しに
April, 17 2018
Back to the Drawing Board for Tesla
wsj.comArticle
Back to the Drawing Board for Tesla
April, 17 2018
Bristol-Myers has Farther to Fall
wsj.comArticle
Bristol-Myers has Farther to Fall
April, 16 2018
How Big Biotech Can Win Back Investors
wsj.comArticle
How Big Biotech Can Win Back Investors
April, 12 2018
Novartis’s $9 Billion Bet Is Worth the Risk
wsj.comArticle
Novartis’s $9 Billion Bet Is Worth the Risk
April, 9 2018
Anthem May Win by Sitting Out Wave of Health Insurance Deals
wsj.comArticle
Anthem May Win by Sitting Out Wave of Health Insurance Deals
April, 6 2018
テスラの業界席巻、幻想に終わるか
jp.wsj.comArticle
テスラの業界席巻、幻想に終わるか
April, 4 2018
Tesla’s Model 3 Is No Model T
wsj.comArticle
Tesla’s Model 3 Is No Model T
April, 3 2018
ウォルマートの医療保険大手買収に湧き上がる疑問
jp.wsj.comArticle
ウォルマートの医療保険大手買収に湧き上がる疑問
March, 30 2018
Healthy Skepticism About Walmart and Humana
wsj.comArticle
Healthy Skepticism About Walmart and Humana
March, 30 2018
テスラ、刻々と迫る「運命の時」
jp.wsj.comArticle
テスラ、刻々と迫る「運命の時」
March, 28 2018
The Clock Is Ticking Faster at Tesla
wsj.comArticle
The Clock Is Ticking Faster at Tesla
March, 28 2018
The Clock is Ticking Faster at Tesla
wsj.comArticle
The Clock is Ticking Faster at Tesla
March, 28 2018
Time for Pharma to Play Defense With Deals
wsj.comArticle
Time for Pharma to Play Defense With Deals
March, 15 2018
Authorship Stats
2Sites320Projects29,050Words
About
Charley Grant is a writer who has produced content for wsj.com and jp.wsj.com
Key Phrases
Diversified Media, Drug Prices, Leading Companies, Wall Street, Adjusted Earnings, Elon Musk, Big Pharma, Health Care, Care Act, Drug Companies
© ClearVoice, Inc.